Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Neoplasms 11Breast Neoplasms 11Obesity 8Motor Activity 7Malnutrition 6Lung Neoplasms 6Prostatic Neoplasms 5Overweight 5Colorectal Neoplasms 5Weight Loss 4Hypertension 4Stroke 3Stomach Neoplasms 3Pancreatic Neoplasms 3Heart Failure 3Diabetes Mellitus 3Cardiovascular Diseases 3Sarcopenia 2Polycystic Ovary Syndrome 2Osteoporosis 2Kidney Diseases 2Inflammation 2Heart Diseases 2Gastrointestinal Neoplasms 2Frailty 2Esophageal Neoplasms 2Endometrial Neoplasms 2Colonic Neoplasms 2Cachexia 2Arthritis 2

Interventions

pembrolizumab 162Carboplatin 144Paclitaxel 125Cyclophosphamide 93130-nm albumin-bound paclitaxel 66Capecitabine 63Gemcitabine 54Doxorubicin 49Albumin-Bound Paclitaxel 45Taxes 42atezolizumab 40Cisplatin 38Nivolumab 34sacituzumab govitecan 32olaparib 32Epirubicin 32Docetaxel 28eribulin 27Specimen Handling 26Bevacizumab 26durvalumab 25camrelizumab 23Drug Therapy 22Biopsy 22Magnetic Resonance Spectroscopy 21toripalimab 18Radiotherapy 17spartalizumab 16Everolimus 15fludarabine 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Triple Negative Breast Neoplasms × Nutrition Assessment × Clear all
NCT06610097 2025-04-23

TNBC Gut Microbiota During Neoadjuvant Treatment

Scripps Health

Phase NA Recruiting
30 enrolled
Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡